Statin Landmark Trials Across the Spectrum of Risk: Primary CV Prevention
Slide lecture program (8 slides): View & Download
- Over Time Additional Risk Factors CanProgress
- ASCOT LLA Trial of Statin in Hypertensive Patients With Additional Risk Factors
- ASCOT LLA Primary End Point: Nonfatal MI and Fatal CHD
- ASCOT LLA Secondary End Point: Fataland Nonfatal Stroke
- HPS: Effects of Statin on Major Coronary Events and Stroke in Diabetic andNondiabetic Patients
- CARDS: Effect of Atorvastatin on thePrimary End Point—Major CV EventsIncluding Stroke
- CARDS: Component End Points
- JUPITER Trial of Statin in People With Elevated CRP: Primary End Point
Click on slides to preview
Download slides below
Share this page with your colleagues and friends: